1. CD146 is closely associated with the prognosis and molecular features of osteosarcoma: Guidance for personalized clinical treatment
   Jingkun Wang et al, 2022, Frontiers in Genetics CrossRef
2. High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells
   Kui Chen et al, 2016, Biochemistry and Biophysics Reports CrossRef
3. MCAM abnormal expression and clinical outcome associations are highly cancer dependent as revealed through pan-cancer analysis
   Yunxia An et al, 2020, Briefings in Bioinformatics CrossRef
4. CD146 expression in oral lichen planus and oral cancer
   Sarinthon Pariyawathee et al, 2020, Clinical Oral Investigations CrossRef
5. CD146 as a prognostic marker in breast cancer: A meta-analysis
   Akshita Sharma et al, 2024, Journal of Cancer Research and Therapeutics CrossRef
6. CD146 T cells in lung cancer: its function, detection, and clinical implications as a biomarker and therapeutic target
   Ayobami Matthew Olajuyin et al, 2019, Cancer Cell International CrossRef
7. Transport, In Vivo Antihypertensive Effect, and Pharmacokinetics of an Angiotensin-Converting Enzyme (ACE) Inhibitory Peptide LVLPGE
   Jingyan Pei et al, 2021, Journal of Agricultural and Food Chemistry CrossRef
8. Advances in the Theranostics of Oesophageal Squamous Carcinoma
   Miaomiao Cheng et al, 2023, Advanced Therapeutics CrossRef
9. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
   Ping Zeng et al, 2017, Scientific Reports CrossRef